Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Drug Manufacturers - Major Cannabis Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp > Looks like Germany’s legalization is in trouble
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(142)
•••
Comment by BrokerGon Mar 22, 2024 9:52am
121 Views
Post# 35946864

RE:RE:Looks like Germany’s legalization is in trouble

RE:RE:Looks like Germany’s legalization is in troubleYes I think shortie is covering however we have three catalysts today:
1] Germany legalizing April 1
2] Canadian tax changes April 16th
3] Possible re-sceduling in US

I think all three have made shortie a little scared. The next question, is what king of a boost we will get if rescheduling happens?. Remember we are only at .71 cents pre-RS. Considering the dilution since then, I would think re-scheduling gets us to at least $18-$20 CDN.

Am i out of line?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities